Key Dates
Related Announcements
December 18, 2024 - NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional). See NOFO PAR-25-032.
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this notice is to inform potential applicants of a change in the key dates for the Notice of Funding Opportunity (NOFO) PAR-25-032 "NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)". Specifically, 1 additional receipt date has been added for new applications and resubmission/revision applications. The NOFO will now expire on March 17, 2027.
The following sections of PAR-25-032 have been updated in bold italics to reflect the additional receipt dates and new expiration date.
Part 1. Overview Information
Key Dates
The following table includes NIH standard due dates marked with an asterisk.
Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
February 16, 2025 * | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
June 16, 2025 * | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
October 16, 2025 * | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
February 16, 2026 * | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
June 16, 2026 * | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
October 16, 2026 * | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
January 08, 2027
Due Dates for E.O. 12372
Not Applicable
Part 1. Overview Information
Key Dates
The following table includes NIH standard due dates marked with an asterisk.
Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
February 16, 2025 * | March 16, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
June 16, 2025 * | July 16, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
October 16, 2025 * | November 16, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
February 16, 2026 * | March 16, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
June 16, 2026 * | July 16, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
October 16, 2026 * | November 16, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
February 16, 2027 * | March 16, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Expiration Date
March 17, 2027
Due Dates for E.O. 12372
Not Applicable
All other aspects of the NOFO remain the same.
Inquiries
Please direct all inquiries regarding this Notice to:
Scientific/Research Contact(s)
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: NOT-HL-27-003
Division of Blood Diseases and Resources, Grant Resources (Non-Clinical Trial Research)
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: NOT-HL-27-003
Division of Blood Diseases and Resources, Clinical Trials
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: NOT-HL-27-003
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: NOT-HL-27-003
Center for Translation Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: NOT-HL-27-003
Financial/Grants Management Contact(s)
Office of Grants Management
National Heart, Lung, and Blood Institute (NHLBI)
Email: [email protected]
Subject: NOT-HL-27-003
and Human Services (HHS)
